glp-1 adoption Agonists Weight Loss Drugs Market Report, 2025-2030 GLP-1 Receptor Agonist Market Size

Patent protections for semaglutide (Ozempic/Wegovy) expire in 2026 in Canada, India, Brazil and China, opening the door for lower-cost biosimilar generic versions

As a pharmacist, I can appreciate the excitement in the rise in oral semaglutide, since it is an easier route than injectables, says Melinda Lee, a pharmacist who runs the pharmaceutical packaging company Parcel Health as well as a GLP-1 drug availability database

When administered under the guidance of our experienced medical team, semaglutide can lead to significant and lasting weight lossoften surpassing the results of diet and exercise alone

Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population

This research offers promising insights for those striving to eat healthier and better control their sugar intake